Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin and exercise in dyslipidemic adults with HIV on antiretroviral therapy
RBR-3fvm6vNot yet recruiting
- Sponsor
- Universidade Federal de Uberlândia
- Start
- Jan 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised trial of rosuvastatin in human immunodeficiency virus infection (HIV) and dyslipidemia (4 arms), sponsored by Universidade Federal de Uberlândia. Planned start Jan 2017; status: not yet recruiting.
02
Drugs
rosuvastatin
03
Conditions
human immunodeficiency virus infection (HIV)dyslipidemia
Beyond the preview
Go deeper on RBR-3fvm6v.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-3fvm6v.